Valiant Laboratories Limited (BOM:543998)

India · Delayed Price · Currency is INR

95.71

+4.24 (4.64%)

At close: Aug 21, 2026

9.12% (1Y)

Market Cap	5.20B +8.7%
Revenue (ttm)	3.06B +89.6%
Net Income	160.14M +12,314.1%
EPS	2.40 +7,963.7%
Shares Out	n/a
PE Ratio	32.47
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,819
Open	92.90
Previous Close	91.47
Day's Range	91.94 - 96.04
52-Week Range	50.00 - 96.04
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Valiant Laboratories

Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and ... [Read more]

Industry Pharmaceutical Preparations

Founded 1980

Employees 79

Stock Exchange Bombay Stock Exchange

Ticker Symbol 543998

Full Company Profile

Financial Performance

In fiscal year 2026, Valiant Laboratories's revenue was 2.37 billion, an increase of 78.04% compared to the previous year's 1.33 billion. Losses were -32.68 million, 48.5% more than in 2025.

Financial Statements